RECQ Helicases: Bloom, Werner and Genome Maintenance
The RECQ family comprises five DNA helicases in humans (RECQL1, BLM, WRN, RECQL4, RECQL5). They unwind unusual DNA structures that arise during replication, recombination and repair. Loss of three of them causes recognised inherited disorders, and one, WRN, has emerged as a synthetic-lethal target in mismatch-repair-deficient cancers.
Quick Answer
The RECQ family comprises five DNA helicases in humans (RECQL1, BLM, WRN, RECQL4, RECQL5). They unwind unusual DNA structures that arise during replication, recombination and repair. Loss of three of them causes recognised inherited disorders, and one, WRN, has emerged as a synthetic-lethal target in mismatch-repair-deficient cancers.
Part of a topic cluster
DNA Repair and Genomic Instability
Open the complete 15-article guideSide-by-side comparison
The three RECQ-helicase deficiency syndromes differ in the gene lost, their hallmark features and the cancers they most strongly predispose to.
| Syndrome | Gene lost | Hallmark features | Cancer emphasis |
|---|---|---|---|
| Bloom syndrome | BLM | Growth restriction, sun sensitivity, raised sister chromatid exchange | Broad, early-onset spectrum |
| Werner syndrome | WRN | Segmental premature ageing | Sarcomas, thyroid, melanoma |
| Rothmund-Thomson syndrome | RECQL4 | Poikiloderma, skeletal anomalies | Osteosarcoma |
What These Helicases Do
RECQ helicases resolve structures such as G-quadruplexes, displacement loops, stalled forks and recombination intermediates. By dissolving double Holliday junctions, BLM suppresses crossover recombination, which limits loss of heterozygosity.
Their substrates sit at the junction of replication and recombination, so RECQ loss tends to produce chromosome instability rather than a single defined mutational signature.
Three Distinct Syndromes
Biallelic BLM loss causes Bloom syndrome: growth restriction, sun sensitivity, and a broad, early cancer predisposition, with a diagnostic excess of sister chromatid exchanges. Biallelic WRN loss causes Werner syndrome, a segmental premature-ageing disorder with sarcomas and other cancers. RECQL4 variants underlie Rothmund-Thomson syndrome and confer osteosarcoma risk.
That the same gene family produces such different phenotypes reflects the non-redundant roles of individual helicases.
WRN as a Synthetic-Lethal Target
Multiple screens found that cancer cells with microsatellite instability depend on WRN helicase activity, apparently because expanded TA-dinucleotide repeats form secondary structures that require WRN to resolve during replication.
WRN inhibitors are in clinical development for MSI-high tumours. This is an active investigational area, and the dependency is specific to the mismatch-repair-deficient context rather than a general feature of cancer.
Testing and the WRN Opportunity
For the inherited syndromes, diagnosis rests on clinical features plus targeted gene testing, with the sister-chromatid-exchange assay still used for Bloom syndrome. Confirmation matters because it changes cancer surveillance and, in some contexts, chemotherapy and radiation tolerance.
On the tumour side, the actionable item is microsatellite-instability status: an MSI-high result now flags a possible WRN dependency, and WRN inhibitors are being tested specifically in that group. A RECQ-family variant found incidentally on a tumour panel, by contrast, rarely changes management.
Key Takeaways
- ·RECQ helicases resolve DNA structures that arise in replication and recombination.
- ·BLM, WRN and RECQL4 loss cause Bloom, Werner and Rothmund-Thomson syndromes respectively.
- ·MSI-high cancers show a WRN dependency now being tested therapeutically.
Put these genes in pathway context
Frequently asked questions
Why are MSI-high cancers sensitive to loss of WRN?
Expanded TA-dinucleotide repeats in mismatch-repair-deficient tumours form secondary DNA structures that need WRN helicase to resolve during replication, creating a synthetic-lethal dependency now being tested with WRN inhibitors.
Do the RECQ helicases do the same job?
No. They have non-redundant roles, which is why BLM, WRN and RECQL4 loss produce three very different syndromes — Bloom, Werner and Rothmund-Thomson — rather than one shared phenotype.
How is Bloom syndrome recognised in the laboratory?
By a diagnostic excess of sister chromatid exchanges, alongside growth restriction, sun sensitivity and a broad early cancer predisposition.
References
Continue Reading
ATM vs ATR: Two DNA-Damage Response Kinases
2 min read
Alternative Lengthening of Telomeres: Telomerase-Independent Immortality
3 min read
The Fanconi Anaemia Pathway: Interstrand Crosslink Repair
3 min read
Whole-Genome Doubling: A Macro-Evolutionary Step in Cancer
3 min read
ATM Kinase and the DNA Damage Response
4 min read
BRCA1 and Ovarian Cancer Risk: How to Read a Result
3 min read
Choose your next research step
Move from this explanation into a gene profile, a pathway map, or the next evidence update.
ATM has 75+ trials currently recruiting on ClinicalTrials.gov. The GeneAnalyses digest summarises the new and changed ones each day.